Together, these findings indicate that human T2DM β-cells exhibit abnormalities in glucose metabolism and in mitochondrial structure and function that result in impaired ATP production and glucose-stimulated insulin secretion [7]. The gene discussed is INS; the disease is type 2 diabetes mellitus.